PTEN and neoplasm: Cellular and tissue context is paramount; the downstream consequences of miR-21 targeting specific genes (like PTEN or PDCD4) may differ significantly depending on the specific GI cell type, the cancer stage, and the surrounding tumor microenvironment (TME).